Since there is insufficient data available about the inter-vendor consistency of three-dimensional (3D) speckletracking (STE) measurements, we undertook this study to (i) assess the inter-vendor consistency of 3D LV global strain values obtained using two different scanners; (ii) identify the sources of inter-vendor inconsistencies, if any; and (iii) compare their respective intrinsic variability.
Introduction
The development of myocardial deformation analysis by echocardiography has allowed the quantitation of the myocardial function at regional and global levels, aiming to render its assessment more objective, accurate and reproducible. 1 Tissue velocity imaging has been the first technique used to calculate myocardial deformation and remains the most extensively evaluated technology for this purpose. 1 However, the accurate measurement of myocardial deformation using Doppler is critically dependent on the angle of insonation; therefore limited to the assessment of its longitudinal component. Two-dimensional strain is a technique of quantifying myocardial deformation from continuous frame-by-frame tracking of acoustic speckles, which is angle independent (provides measurements of three deformation components: longitudinal, radial and circumferential), less subject to artefacts, and simpler to obtain than Doppler-derived tissue velocity imaging. 1 However, cardiac motion is a complex combination of apex-to-base lengthening and shortening with simultaneous twisting and therefore speckle tracking methods based on two-dimensional imaging are limited by the significant speckle decorrelation when out-of-plane motion occurs. Therefore, the accurate evaluation of myocardial strain in the left ventricular (LV) myocardial segments requires an advanced technology that uses a three-dimensional (3D) tracking system. The newly developed 3D speckle-tracking echocardiography (3D STE) based on 3D data sets has the potential to circumvent the limitations of two-dimensional STE in the assessment of LV myocardial deformation.
Although several clinical applications of 3D STE have been reported to assess the regional 2 -4 and global 5 -10 LV function, to quantify the LV dyssynchrony 11 -14 and to evaluate the LV myocardial function in hypertensive disease, 15 data about reproducibility of the technique are scarce and restricted to a single echo machine. 3, 16 There is a single paper reporting the inter-vendor consistency of 3D STE measurements, but only in normal subjects and involving only one of the commercially available echo platforms which provide the 3D STE package on board. 17 Knowledge of these data about commercially available echo platforms in patients examined in routine clinical practice is pivotal for this technique to be implemented in both clinical and research arenas. Accordingly, in the present study we used the two commercially available platforms equipped with 3D STE technique to obtain, in the same patient, two 3D STE measurements of LV deformation parameters in order to (i) assess their inter-vendor consistency; (ii) investigate their intrinsic variability by assessing their interand intra-observer, as well as test/re-test reproducibility; and (iii) identify some of the sources of inter-vendor inconsistencies, if any.
Methods

Study population
Seventy-one consecutive patients, referred as in-or outpatients to our echo-lab for a clinically indicated routine echocardiography, were enrolled in the study.
The unique inclusion criteria were the presence of sinus rhythm and ability to breathhold for 5 -10 s during the examination. Eleven patients (15%) were excluded due to poor 2D image quality (more than two LV segments not adequately visualized without contrast infusion) or persistent stitching artefacts at several 3D data set acquisitions. Accordingly, the patient study group consisted of 60 patients ( Table 1) .
Echocardiography
All examinations were performed with commercially available echocardiographic systems (Vivid E9, GE-Healthcare, Horten, Norway, and Artida, Toshiba Medical Systems Corporation, Tokyo, Japan) equipped with the 4V and the PST-25SX phased-array matrix transducers, respectively. Two 3DE LV data sets were acquired by the same experienced examiner at the beginning and at the end of the standard echocardiographic examination using both echo platforms in sequence and without changing the patient position. Consecutive four-beat ECG-gated subvolumes were acquired from the apical approach using second-harmonic imaging, during an end-expiratory apnoea to generate the full-volume data set using the wide-angle default settings of each scanner recommended by the two manufacturers. 15, 18 Care was taken to encompass the entire LV cavity within the data set. The quality of the acquisitions was then verified in each patient by selecting the multislice display mode available on the machines to ensure optimal imaging of the entire LV wall at each short-axis level and, if unsatisfactory, the data set were re-acquired. Data sets were digitally stored in a raw-data format and exported to separate workstations equipped with the two commercially available softwares (EchoPAC v110.1.3, GE Healthcare, Horten, Norway, and 3D WMT, Toshiba Medical Systems Corporation, Tokyo, Japan) for offline analysis of STE LV myocardial deformation measurements, together with LV volumes, mass and ejection fraction quantitation.
3D-strain measurements
A single experienced investigator analysed the data sets in random order, unaware of the identity of the patients. Data sets acquired with Artida were displayed in a 5 slice mode (Figure 1 A) . The LV was automatically divided into 17 3D segments using standard segmentation. 19 The following parameters of global myocardial deformation (Lagrangian strain) were measured: longitudinal (L1), circumferential (C1), radial (R1) and area (A1) strain. Measurements were performed using a methodology extensively described by Seo et al. 2 and time -strain curves were displayed with drift compensation of any segmental trace and temporal strain-volume variations presented in a wide variety of colour-coded displays (Figure 1 A) . Data sets acquired with Vivid E9 were analysed using the 4D-AutoLVQ package (EchoPAC v110.1.3, GE-Healthcare, Horten, Norway). The end-diastolic frames needed for contour detection were automatically displayed in a quad view (Figure 1 B) . Manual alignment by pivoting and translating the four-chamber plane was performed to align the three apical views in order that the corresponding intersection line of all planes was placed in the middle of the LV cavity, crossing the LV apex and the centre of mitral valve in each view. We used the semi-automated option to subsequently identify a fitting geometric model. The software required the manual input of only two single points (one point at the apex and another one at the tip of the mitral leaflet) on the end-diastolic and end-systolic frames of the four-chamber view slice. After LV volumes and ejection fraction measurements, an automatic trace of the epicardial border was displayed to identify the region of interest required for LV mass and myocardial deformation measurements by 3D STE. Epicardial trace could be manually adjusted with the same point-click method. The deformation parameters were reported as global (both peak and end-systolic) and regional (endsystolic) L1, C1, R1 and A1, and presented as color-coded polar maps and time -strain traces of an LV 17-segment model. As opposed to the 3D WMT software, the 4DAutoLVQ package does not apply any drift compensation to strain curves, and LV segments showing a significant drift of L1 (more than 12 percentage points) of end-systolic strain curves from the baseline were rejected from the subsequent analysis (Figure 1 B) . Global strain was not computed when more than three LV segments were rejected and these patients were excluded from the final analysis.
The mean time spent for the analysis with each software was recorded for subsequent comparison.
The inter-vendor consistency of 3D strain measurements was assessed by comparing the measurements of each strain component obtained with these two products.
Reproducibility of 3D strain measurements
To explore the impact of the intrinsic variability of repeated measurements on inter-vendor strain differences, we assessed the intra-, interobserver and test/re-test reproducibility on 20 randomly selected LV data sets. To test the intra-observer variability, a single observer analysed the same data sets on two different occasions separated by 1-week interval. To test the inter-observer variability, a second observer analysed the data without knowledge of the first observer's measurements. Test/re-test variability was assessed by comparing the measurements obtained by the same observer from the data set acquired at the beginning of the routine echo study and from the second one acquired at the end of the echo study (around 40 min later) using the same platform.
Analysis of sources of inter-vendor inconsistency
In order to explore the reasons for the observed differences between the two vendors, we analysed the influence of the specific software Figure 1 Left ventricular data set display with 3D speckle-tracking analysis of myocardial deformation using Artida (A) and Vivid E9 (B) platforms. On the right side of each panel, the derived time -strain curves are shown. Time -strain curves obtained with Artida show a drift compensation (i.e. all curves are forced to reach the zero baseline at end diastole: upper right panel). This does not apply to the time -strain curves provided by Vivid E9 (lower right panel), a large drift (.12%) leading to automated segment rejection by this software; a time -strain curve with a significant drift is highlighted in yellow.
Inter-vendor inconsistency of 3D strain values used, image quality, and temporal resolution of 3D data sets on 3D strain measurements.
The influence of the softwares used to analyse the 3D data sets was assessed by comparing 3D strain results obtained by a single observer who analysed all 3D data sets acquired with both platforms with a vendor-independent software (4D LV Analysis, TomTec Imaging Systems, Unterschleissheim, Germany). Image quality of 3D data sets was independently scored by two observers by looking at sliced images and was graded as poor (incomplete endocardial border visualization), fair (complete, but suboptimal visualization of endocardial border) and good (clear visualization of the whole edocardial border). In the case of disagreement between the two observers, a consensus was reached by joint review. 3D strain measurements obtained from data sets scored as having good quality with both platforms were compared. In addition, the number of LV segments which did not enter within the image sector of the sliced data sets was collected.
To test the influence of data set temporal resolution on the intervendor consistency of 3D strain measurement, in 15 patients an additional data set was acquired with Artida at 30 vps immediately after the reference one in order to reach the same temporal resolution of data sets acquired with Vivid E9.
The study protocol was approved by our Institutional Ethics Committee and all patients gave informed consent consistent with this protocol.
Statistical analysis
Data are summarized as the mean + SD, frequencies and ranges, as appropriate. Continuous data were compared with the two-tailed Student's t-test for paired and unpaired data, respectively. For each deformation parameter, the consistency between each pair of measurements obtained with the two platforms was assessed using Bland -Altman statistics to calculate the systematic bias and limits of agreement (LOA) and with Pearson's correlation coefficients. Intraand inter-observer, as well as the test/re-test variability were assessed using Bland -Altman statistics (coefficient of repeatability, CR) and intra-class correlation (intra-class correlation coefficient, ICC). Comparison of Pearson's correlation coefficients was performed using the Z score statistic. A probability value of ,0.05 was considered statistically significant. Data analysis was performed using SPSS version 15.0 (SPSS, Inc., Chicago, IL, USA) and MedCalc for Windows, 11.4.3.0 release (Mariakerke, Belgium) statistical softwares.
Results
Feasibility of 3D LV data set acquisition was 85% (60 out of 71 attempted) and the final study group comprised 60 patients with a wide range of age and body surface areas ( Table 1) , LV volumes and ejection fractions ( Table 2 ). An average heart rate was similar between data sets acquired with Artida and Vivid E9 ( Table 2) . Conversely, the data set volume size was significantly lower and temporal resolution was significantly higher for those acquired with Vivid E9 ( Table 2 ). The quality of sliced images obtained from the 3D data sets was significantly better with Vivid E9 (Table 2) . However, the larger volume size obtained by Artida allowed to achieve a more complete visualization of LV segments using multislice display: incomplete visualization (i.e. 1-3 missing apical segments) was 28% with Vivid E9 and 2% with Artida (P , 0.0001).
All segments from all available data sets (100%) were analysed with the 3D WMT software. Conversely, two patients with more than three LV segments rejected by automatic tracking using 4DAutoLVQ software by EchoPac were excluded because inadequate for global strain determination. Sixty-four LV segments (6.3%) from the remaining 58 patients were rejected because of significant drift of the strain traces. Inadequately tracked segments were more likely located at the basal level of the LV with a gradient towards mid-ventricle and apical regions (Figure 2) .
The entire time required to analyse the 3D data sets and obtain the final results was not statistically different between the two platforms ( Table 3) . Artida platform produced significantly higher absolute values of both C1 and A1 than Vivid E9 ( Table 3 ). L1 and R1 obtained with Artida were significantly lower than those measured using Vivid E9 platform (Table 3, Figure 3 ). Among the various strain measurements, L1 showed the smallest bias and the narrowest LOA between the two platforms. Conversely, R1 showed the largest bias and the widest limits of LOA between vendors, as well as the poorest correlation among all strain components (Table 3, Figure 4 ).
Reproducibility
Reproducibility of the strain measurements obtained with the two ultrasound systems are summarized in Table 4 . L1 and C1 were found to be comparably and highly reproducible with both vendors (Table 4) . Among all strain components, R1 was the least reproducible parameter with both systems. Overall, the reproducibility of the different strain components was significantly better with Vivid E9 than with Artida ( Table 4) .
Impact of image quality and temporal resolution
Data sets obtained from 22 patients were graded as 'good quality' with both software packages and underwent a subset analysis to assess the inter-vendor consistency of 3D strain measurements ( Table 5) . Selecting only the data sets with good image quality for analysis showed a trend towards an improved inter-vendor correlation of strain measurements, but it did not change the main results of the analysis performed on the whole study population. Apart L1, all strain components differed significantly between the two ultrasound systems and the extent of biases and LOA were comparable between the subset of patients with good image quality and the whole study population.
To assess the impact of temporal resolution on 3D STE deformation measurements, we compared 3D strain measurements obtained from Artida data sets acquired at 20 vps (default settings) and at 30 vps (a volume rate similar to the one reached with Vivid E9). All four strain components showed no significant difference in their values between data sets acquired at 20 vps and those acquired at 30 vps ( Table 6) .
When a vendor-independent software was used to assess L1 in order to eliminate the potential variability due to vendor-specific analysis softwares, we found a significant difference between L1 values obtained examining the data set acquired using Artida and Vivid E9 (214.3 + 5.3 and 212.9 + 4.3%, respectively, P ¼ 0.0001, bias ¼ 21.4, LOA ¼ 4.9 + 0.1%).
Discussion
The main results of our study can be summarized as follows: (i) the inter-vendor agreement of R1, C1 and A1 measured with Artida and Vivid E9 was poor; (ii) only L1 was comparable between the two vendors and also with values obtained with TomTec w software; (iii) the intrinsic variability of the different strain components obtained with the two systems tested was relatively low (except for R1), but varied significantly among strain parameters and between the two vendors; (iv) increasing data set temporal resolution from 20 to 30 vps and image quality do not seem to impact significantly on the inter-vendor agreement of strain measurements; and (v) the use of a vendor-independent analysis software did not eliminate the differences in the L1 measurement.
The development of the 3D STE technique allows one to detect in a fast and comprehensive manner all the components (vectorial and rotational) of the myocardial deformation, without the intrinsic limitations of previous technologies based on tissue velocity imaging or two-dimensional STE. 3, 16, 21 However, since an accurate and reproducible assessment of the LV myocardial function is pivotal for both clinical and research purposes, 3D used for quantitation of myocardial deformation should be evaluated as rigorously as any therapeutic intervention before starting its systematic application in everyday clinical practice. 22 For these reasons, along with the accuracy that should be determined by comparing the measurements with those performed with a reference technique, reproducibility (represented by the reciprocal of the variability of measurements made by a single observer in different occasions-intra-observer variability or by different observers-inter-observer variability) and repeatability (the reciprocal of variability of measurements made on the same patients, in the same conditions in two different occasions-test/re-test variability or made using different systems and analysis softwaresinter-vendor variability) are crucial factors in determining the clinical relevance and reliability of any diagnostic technique. To our knowledge, this is the first study comparing the intervendor consistency and the intrinsic variability of 3D strain measurements obtained with two commercially available echocardiographic platforms in patients with a wide range of LV size and function. Gayat et al. 17 compared strain values measured on data sets acquired from 30 subjects with the normal LV function using Artida and iE33 (Philips Healthcare, Andover, Massachusetts, USA) and analysed them using 3D WMT and 4D LV function software packages. Inter-vendor inconsistency of 3D strain values poor (it improved when data sets acquired with different platforms were analysed using a vendor-independent software, i.e. the 4D LV function), and that the discordance level was beyond the intrinsic measurement variability of any of the tested combinations of software and hardware. However, they analysed only subjects with the normal LV function and measured only longitudinal and circumferential components of strain. Finally, they did not assess an important parameter to consider when a technique has to be used to follow patients, which is the test/re-test variability of measurements.
In our study population, 3D STE was reasonably feasible and measurements were reproducible (except for R1, Table 4 ) with both echocardiographic platforms. However, our data show that, among the various strain components, only the L1 (despite being significantly different between the two systems) was at some extent comparable between Artida and Vivid E9. C1 and A1 showed the mean differences between the two platforms around 30 and 23%, respectively. Figure 3 Comparison of longitudinal, circumferential, radial and area strain obtained from the same patient using Artida (upper panels) and Vivid E9 (lower panels). Only the global longitudinal component of the strain was comparable between the two platforms. However, looking at segmental values, also the longitudinal component of the strain showed significant differences between the two platforms. Notice that the bull's eyes in the lower panels are rotated clockwise by 608 and the segments at 12 o'clock represent the anterior septum.
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respectively), that it seems as if they were measured with different scales. However, R1 obtained with the two systems used in our study seems to measure different entities, since the ICC between R1 measured with Artida and Vivid E9 was only moderate. This is mainly due to the different ways used by the two platforms to compute R1. R1 by 3D WMT is estimated by both endocardial and epicardial speckle tracking, so that R1 measurements are highly dependent on image quality compared with those of the L1 and C1 components, which are estimated only by endocardial speckle data. 4 This translates in a lower accuracy and reproducibility of R1 with this platform in comparison with C1 and L1, 2,4 consistent with our data. Conversely, EchoPAC does not actually measure the R1, but it estimates it from A1, assuming that each LV segment maintains a constant volume throughout cardiac cycle. This explains the high reproducibility and repeatability of R1 calculations obtained with EchoPAC. Noticeably, the inter-vendor biases for all strain measurements were significantly larger than the intrinsic technique variability of each ultrasound system, as detected by the reproducibility and repeatability analyses.
Trying to find out whether any technical reason could explain such different measurements, we found that neither temporal resolution (at least in the range of volume rates tested in our study, i.e. from 20 to 30 vps), nor image quality have a significant impact on the different measurements obtained from the two tested platforms. However, it should be acknowledged that data sets with poor image quality were excluded from our study and that, given the high intrinsic variability of 3D strain estimates, the impact of the remaining range of image quality could have been too small to be detected with the size of our study population. Moreover, C1 and A1 by Artida showed significantly higher amplitudes than those obtained by VividE9, while R1 by Artida was significantly lower than the one obtained by VividE9. Even if some differences can be explained by the fact that 3D WMT tracks mainly speckles located in the endocardial layer and global strains are calculated as mathematical averages of all segmental values, while EchoPAC tracks speckles across the whole wall thickness and global strains are calculated as weighted spatial averaging of segmental values, these seem to be only part of the problem.
On the other end, this is confirmed by the fact that L1 measurements provided by the two vendors are quite close. However, we have found that two data sets acquired in the same patients during the same echocardiographic study by Artida and Vivid E9 and analysed using a single vendor-independent software (i.e. 4D LV function) provide L1 measurements which are discordant beyond the intrinsic variability of the respective ultrasound systems. This is likely linked to the 3D data set characteristics, which differ from vendor to vendor. The ability of a given software package to accurately track wall motion may be affected by these 3D data set characteristics. Inter-vendor inconsistency of 3D strain values
Study limitations
First, our study population was relatively limited. However, we enrolled a two-fold higher number of patients than in similar papers addressing the issue of the inter-vendor consistency of strain measurements, 17, 23 and differently from the previous studies we included patients with an impaired LV function. Secondly, data set temporal resolution and volume size differed significantly between the tested ultrasound systems. However, we used standard machine settings on purpose in order to assess the intervendor agreement of measurements performed with the systems settings used in the clinical routine. Moreover, we have also shown that strain measurements obtained with Artida at standard settings were similar to those obtained at higher volume rates which were similar to those obtained with Vivid E9. Third, image quality was judged visually and not assessed on an objective scale. Thus, the scoring of the data sets in terms of image quality might have been inaccurate. However, we are not aware of any accepted objective grading system for the quality of 3D images.
Conclusions
Since peak strain values obtained from different ultrasound systems are not comparable, clinicians willing to translate 3D STE data from the literature into clinical decision making should take into account the specific system used in their echocardiographic laboratory and reference values of the strain components should be developed for each ultrasound system. Moreover, clinicians who want to use myocardial deformation parameters in longitudinal studies should ensure that baseline and follow-up acquisitions are obtained using the same platform. Since these are major limitations to the implementation of myocardial deformation parameters in the clinical practice and to the spread of the technique across echocardiographic laboratories, manufacturers are urged to take initiatives in order to overcome those variations and provide a common standard of two-dimensional and 3D strain measurement across vendors.
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